Bayforest Capital Ltd Invests $417,000 in Medical Properties Trust, Inc. $MPW

Key Points

• Bayforest Capital Ltd has acquired a new stake in Medical Properties Trust, purchasing 69,175 shares valued at approximately $417,000.
• Wells Fargo & Company and Royal Bank of Canada recently reduced their price targets on Medical Properties Trust from $5.00 to $4.50, reflecting a cautious outlook on the stock.
• The company will pay a quarterly dividend of $0.08 per share on October 9th, representing a 7.0% dividend yield.

Bayforest Capital Ltd purchased a new position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 69,175 shares of the real estate investment trust's stock, valued at approximately $417,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Charles Schwab Investment Management Inc. raised its position in Medical Properties Trust by 13.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock worth $60,424,000 after acquiring an additional 1,182,028 shares in the last quarter. Allianz Asset Management GmbH raised its position in Medical Properties Trust by 43.2% in the first quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock worth $43,022,000 after acquiring an additional 2,152,861 shares in the last quarter. Northern Trust Corp raised its position in Medical Properties Trust by 1.5% in the first quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust's stock worth $38,620,000 after acquiring an additional 95,525 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Medical Properties Trust by 11.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust's stock worth $24,644,000 after purchasing an additional 410,374 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Medical Properties Trust by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,676,474 shares of the real estate investment trust's stock worth $14,522,000 after purchasing an additional 150,760 shares in the last quarter. 71.79% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on MPW. Zacks Research raised Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. Royal Bank Of Canada dropped their price target on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research note on Monday, June 30th. Wells Fargo & Company dropped their price target on Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating on the stock in a research note on Wednesday, August 27th. Finally, Wall Street Zen cut Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $5.40.

Medical Properties Trust Stock Performance

MPW traded down $0.28 on Monday, hitting $4.86. The company had a trading volume of 6,952,258 shares, compared to its average volume of 10,298,796. The company's fifty day moving average price is $4.28 and its 200 day moving average price is $4.85. Medical Properties Trust, Inc. has a 1-year low of $3.51 and a 1-year high of $6.55. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.76 and a quick ratio of 2.76. The stock has a market cap of $2.92 billion, a price-to-earnings ratio of -2.03 and a beta of 1.35.

Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The company had revenue of $240.36 million during the quarter, compared to analyst estimates of $231.90 million. During the same quarter last year, the firm posted $0.23 earnings per share. The firm's revenue for the quarter was down 9.8% compared to the same quarter last year. Equities analysts predict that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current fiscal year.

Medical Properties Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 9th. Stockholders of record on Thursday, September 11th will be issued a dividend of $0.08 per share. The ex-dividend date is Thursday, September 11th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 6.6%. Medical Properties Trust's payout ratio is -13.39%.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.